News

The folate-appended CD derivatives useful for targeting cancer cells, Curcumin/HPBCD complex fixed in sacran gels for accelerating wound healing, and pegylated insulin/GCD formulation for sustained release were introduced. The new developments in protein delivery (SPRA technology), CD modified with cell penetrating peptides against Niemann Pick disease and CD-dendrimer conjugates for gene delivery were demonstrated. After the talk we had a stimulating discussion on these cutting edge projects.

BACK TO NEWS